SCLX (Scilex Holding Company Common Stock) Stock Analysis - AI Report
Scilex Holding Company Common Stock (SCLX) is a publicly traded Healthcare sector company. As of May 21, 2026, SCLX trades at $6.06 with a market cap of $42.06M and a P/E ratio of -0.17. SCLX moved +1.84% today. Year to date, SCLX is -54.68%; over the trailing twelve months it is +20.20%. Its 52-week range spans $3.60 to $39.90. Rallies surfaces SCLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on SCLX?
Rallies AI research for SCLX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Scilex Holding Co sold 9.66M (~$5.21M) on Dec 30, 2025.
Scilex Holding Co sold 7.31M (~$4.79M) on Dec 29, 2025.
Scilex Holding Co sold 3.69M (~$2.77M) on Dec 26, 2025.
SCLX Analyst Consensus
SCLX analyst coverage data. Average price target: $0.00.
Common questions about SCLX
What is the AI research view on SCLX?
Rallies AI research for SCLX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SCLX?
Rallies AI research for SCLX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SCLX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCLX. It does not provide personalized investment advice.
